1. In previous studies we have shown that, after the administration of
adriamycin, hypertension developed in rats who became pregnant (adria
mycin-pregnant rats), whereas virgin animals remained normotensive. Su
bsequently, we showed that this hypertension was prevented by administ
ration of L-arginine, suggesting that deficient synthesis of nitric ox
ide may be pathogenetic in this model. 2. To further assess the role o
f nitric oxide in this model, we measured mean arterial blood pressure
after administration of L-arginine to adriamycin-pregnant rats or of
N-G-nitro-L-arginine-methyl ester (L-NAME) to normal pregnant rats. In
other experiments, we assessed the response of isolated perfused arte
rial mesenteric vessels, precontracted with noradrenaline, to acetylch
oline, L-arginine or L-NAME. 3. Blood pressure was decreased in normal
pregnant rats, whereas it was elevated in adriamycin-pregnant rats. L
-NAME treatment increased blood pressure in normal pregnant rats and L
-arginine decreased it in adriamycin-pregnant rats. 4. Mesenteric vess
els of adriamycin-pregnant rats exibited an exaggerated vasoconstricto
ry response to noradrenaline, when compared with the blunted response
observed in normal pregnancy. The addition of L-NAME in vitro induced
a further contraction, significantly greater in normal pregnant rats.
The vasodilatory response to acetylcholine and L-arginine was greater
in vessels from adriamycin-pregnant rats. In contrast, responses to ei
ther nitroprusside or diazoxide were similar in all groups. 5. The res
ults suggest a state of reduced nitric oxide synthesis in rats with ad
riamycin nephropathy, leading to vascular maladaption and hypertension
in pregnancy.